Emily McGibbon

1.8k total citations
17 papers, 421 citations indexed

About

Emily McGibbon is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Emily McGibbon has authored 17 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 7 papers in Epidemiology and 7 papers in Modeling and Simulation. Recurrent topics in Emily McGibbon's work include COVID-19 epidemiological studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Hepatitis B Virus Studies (5 papers). Emily McGibbon is often cited by papers focused on COVID-19 epidemiological studies (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Hepatitis B Virus Studies (5 papers). Emily McGibbon collaborates with scholars based in United States. Emily McGibbon's co-authors include Mary Huynh, Gretchen Van Wye, Donald R. Olson, Hiu Tai Chan, Katherine Bornschlegel, Sharon K. Greene, Anne D. Fine, Sharon Balter, Wenhui Li and Sasikiran Kandula and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and The Lancet Infectious Diseases.

In The Last Decade

Emily McGibbon

17 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emily McGibbon United States 9 215 132 107 84 54 17 421
Jennifer Baumgartner United States 9 106 0.5× 66 0.5× 116 1.1× 68 0.8× 69 1.3× 15 326
Shazaad Ahmad United Kingdom 12 302 1.4× 96 0.7× 81 0.8× 56 0.7× 12 0.2× 25 481
Mercedes Yanes‐Lane Canada 8 229 1.1× 88 0.7× 110 1.0× 29 0.3× 16 0.3× 14 364
Reiko Miyahara Japan 12 202 0.9× 140 1.1× 135 1.3× 33 0.4× 24 0.4× 32 456
Athanasia Lourida Greece 11 178 0.8× 76 0.6× 131 1.2× 28 0.3× 19 0.4× 24 368
Manel Cervantes Spain 8 228 1.1× 38 0.3× 86 0.8× 47 0.6× 39 0.7× 8 503
Johanne E. Morne United States 7 498 2.3× 156 1.2× 86 0.8× 55 0.7× 21 0.4× 9 605
Anna Nguyen United States 7 170 0.8× 131 1.0× 82 0.8× 19 0.2× 12 0.2× 20 356
Cécile Kremer Belgium 8 239 1.1× 323 2.4× 160 1.5× 21 0.3× 63 1.2× 21 498
Banafsheh Moradmand Badie Iran 10 247 1.1× 26 0.2× 124 1.2× 51 0.6× 32 0.6× 29 405

Countries citing papers authored by Emily McGibbon

Since Specialization
Citations

This map shows the geographic impact of Emily McGibbon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily McGibbon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily McGibbon more than expected).

Fields of papers citing papers by Emily McGibbon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily McGibbon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily McGibbon. The network helps show where Emily McGibbon may publish in the future.

Co-authorship network of co-authors of Emily McGibbon

This figure shows the co-authorship network connecting the top 25 collaborators of Emily McGibbon. A scholar is included among the top collaborators of Emily McGibbon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily McGibbon. Emily McGibbon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Fitzhenry, Robert, Bruce Gutelius, Amy K. Alderman, et al.. (2024). Symptomatic Entamoeba dispar Infections Among Men Who Have Sex With Men, New York City, 2018. Open Forum Infectious Diseases. 11(12). ofae658–ofae658. 1 indexed citations
2.
Levin‐Rector, Alison, Lauren Firestein, Emily McGibbon, et al.. (2022). Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021–November 2021. Clinical Infectious Diseases. 76(3). e469–e476. 8 indexed citations
3.
Greene, Sharon K., Alison Levin‐Rector, Nang Thu Thu Kyaw, et al.. (2022). Comparative hospitalization risk for SARS‐CoV‐2 Omicron and Delta variant infections, by variant predominance periods and patient‐level sequencing results, New York City, August 2021–January 2022. Influenza and Other Respiratory Viruses. 17(1). e13062–e13062. 16 indexed citations
4.
Ngai, Stephanie, Jessica Sell, Maryam Iqbal, et al.. (2022). Built by epidemiologists for epidemiologists: an internal COVID-19 dashboard for real-time situational awareness in New York City. JAMIA Open. 5(2). ooac029–ooac029. 2 indexed citations
5.
Thomas, Sarah, Sara H. Soshnick, Emily McGibbon, et al.. (2021). A fatal case report of antibody-dependent enhancement of dengue virus type 1 following remote Zika virus infection. BMC Infectious Diseases. 21(1). 749–749. 19 indexed citations
6.
Greene, Sharon K., Alison Levin‐Rector, Emily McGibbon, et al.. (2021). Reduced COVID-19 hospitalizations among New York City residents following age-based SARS-CoV-2 vaccine eligibility: Evidence from a regression discontinuity design. Vaccine X. 10. 100134–100134. 7 indexed citations
7.
Akinbami, Lara J., Brad J. Biggerstaff, Philip A. Chan, et al.. (2021). Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders. Clinical Infectious Diseases. 75(1). e201–e207. 19 indexed citations
8.
Thompson, Corinne N., Scott Hughes, Stephanie Ngai, et al.. (2021). Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant — New York City, New York, January 1–April 5, 2021. MMWR Morbidity and Mortality Weekly Report. 70(19). 712–716. 36 indexed citations
9.
Olson, Donald R., Mary Huynh, Annie D. Fine, et al.. (2020). Preliminary Estimate of Excess Mortality During the COVID-19 Outbreak — New York City, March 11–May 2, 2020. MMWR Morbidity and Mortality Weekly Report. 69(19). 603–605. 124 indexed citations
10.
Yang, Wan, Sasikiran Kandula, Mary Huynh, et al.. (2020). Estimating the infection-fatality risk of SARS-CoV-2 in New York City during the spring 2020 pandemic wave: a model-based analysis. The Lancet Infectious Diseases. 21(2). 203–212. 115 indexed citations
11.
McGibbon, Emily, Neil M. Vora, Alan P. Dupuis, et al.. (2018). Epidemiological Characteristics and Laboratory Findings of Zika Virus Cases in New York City, January 1, 2016–June 30, 2017. Vector-Borne and Zoonotic Diseases. 18(7). 382–389. 3 indexed citations
12.
Conners, Erin E., Ellen H. Lee, Corinne N. Thompson, et al.. (2018). Zika Virus Infection Among Pregnant Women and Their Neonates in New York City, January 2016–June 2017. Obstetrics and Gynecology. 132(2). 487–495. 14 indexed citations
13.
Moore, Miranda S., Angelica Bocour, Emily McGibbon, et al.. (2017). Development and Validation of Surveillance-Based Algorithms to Estimate Hepatitis C Treatment and Cure in New York City. Journal of Public Health Management and Practice. 24(6). 526–532. 11 indexed citations
14.
Halperin, Jason, Asher J Schranz, Fabienne Laraque, et al.. (2015). Hepatitis C Surveillance Markers Study: A Validation of Genotype as a Laboratory Proxy for Linkage to Care. Open Forum Infectious Diseases. 2(suppl_1). 2 indexed citations
15.
Tsai, Victoria, Katherine Bornschlegel, Emily McGibbon, & Stephen M. Arpadi. (2014). Duplicate Hepatitis C Antibody Testing in New York City, 2006–2010. Public Health Reports. 129(6). 491–495. 5 indexed citations
16.
McGibbon, Emily, Katherine Bornschlegel, & Sharon Balter. (2013). Half a Diagnosis: Gap in Confirming Infection among Hepatitis C Antibody-positive Patients. The American Journal of Medicine. 126(8). 718–722. 34 indexed citations
17.
Bornschlegel, Katherine, et al.. (2013). Enhanced Chronic Hepatitis C Surveillance in New York City, April 2009–January 2011. Public Health Reports. 128(6). 510–518. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026